4D MOLECULAR THERAPEUTICS, INC. (FDMT)
4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial of 4D-150 in Wet AMD
4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial of 4D-150 in Wet AMD
Masco Corporation Announces Date for Earnings Release and Conference Call for 2026 Second Quarter
ChargePoint Added to Membership of Russell 2000® Index
Family Offices Turning to “Purpose of Wealth” to Prepare the Next Generation, New AlTi Tiedemann Global and Campden Wealth Research Finds
Virtus Total Return Fund Inc. Discloses Sources of Distribution – Section 19(a) Notice
Virtus Diversified Income & Convertible Fund Discloses Sources of Distribution – Section 19(a) Notice
19% of House Hunters Are Looking to Relocate—And They’re Headed to the Sun Belt
Swarmer Adds Additional $1M in Revenue From SkyKnight Contract Update That Expands Swarming Software To Czech Republic
Futu Holdings Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – FUTU
Tigo Energy Announces Inclusion in Russell 3000® Index